Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Natural History Study of Mitochondrial Neurogastrointestinal Encephalomyopathy

NCT04245917 is registered in ClinicalTrials.gov with Entrada Therapeutics, Inc. as lead sponsor.

NCT NCT04245917
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04245917 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Natural History Study of Mitochondrial Neurogastrointestinal Encephalomyopathy
Lead sponsor
Entrada Therapeutics, Inc.
Phase
Observational
Overall status
Suspended
Start date
August 6, 2020
Completion date
February 28, 2026
Enrollment
60 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

mitochondrial neurogastrointestinal encephalomyopathy